Osteoporosis

What is the role of medicines in osteoporosis care?

Osteoporosis treatment aims to reduce the risk of fractures by supporting bone strength. Medicine choice is usually considered alongside factors such as fracture risk, age, menopause status, other health conditions and whether a person has already had a fracture. Adequate calcium and vitamin D intake, weight-bearing activity where appropriate, and falls prevention may also form part of a broader care plan.

Which medicine approaches are used for osteoporosis in Australia?

Several medicine families may be considered for osteoporosis, depending on clinical circumstances. These include antiresorptive medicines such as bisphosphonates and denosumab, bone-building treatments for selected higher-risk patients, and hormone-based approaches in suitable postmenopausal patients. Systemic oestrogen has a long-established role in helping prevent postmenopausal bone loss, but it is not the same treatment approach as every other osteoporosis medicine. A prescriber can help determine which treatment role is appropriate.

What should I consider before selecting a treatment option?

It is useful to distinguish prevention of further bone loss from treatment chosen after a fracture or for a higher assessed fracture risk. The active ingredient, treatment goal, dosage form, strength, prescription requirements and your clinician's advice all matter. Different medicine families should not be treated as interchangeable simply because they are included in osteoporosis care.

What do we list in this osteoporosis category?

We list Estrace estradiol tablets, an oral oestrogen option available in 1 mg and 2 mg strengths. For 1 mg, we offer packs of 60, 90, 120, 180, 270 and 360 tablets, with prices from A$176.32. For 2 mg, pack sizes run from 30 to 360 tablets, with prices from A$139.84. The lowest listed unit price is A$2.25 per tablet for the 1 mg 360-tablet pack.

What should Australian customers know about prescription status?

Oestrogen treatment requires clinical assessment and is not a self-selected substitute for other osteoporosis therapies. In Australia, estradiol valerate tablets marketed as Progynova in 1 mg and 2 mg strengths are Australian registered Schedule 4 Prescription Only Medicines. This information does not establish the Australian registration or prescription classification of every estradiol product; please follow the requirements shown during ordering and seek advice from a qualified prescriber.

How do delivery and product handling work?

We can dispatch this category to Australia by Express delivery with tracking, estimated at 4-7 days, or Standard delivery, estimated at 14-21 days. Express shipping costs A$45.58 and Standard shipping costs A$22.78. Free shipping is available for either method when its respective checkout threshold is reached. We accept Visa, Mastercard, Bitcoin and USDT.

For product handling, the listed estradiol tablets should be stored at 20°C to 25°C, with brief excursions permitted between 15°C and 30°C, and the container kept tightly closed. We package medicines carefully for standard postal delivery. Prompt receipt and correct storage after delivery help keep the order in good condition. One published customer review noted that the received tablets matched the ordered strength and form.